Applied BioCode Showcases Comprehensive Pathogen Diagnostic Panels

Source: Applied BioCode ( Healthcare+ Expo- booth no.: M403)

Applied BioCode, multiplex diagnostics company, exhibits at 2024 Taiwan Healthcare+ Expo, showcasing comprehensive and flexible multiplex diagnostics solution, strides forward to gain global diagnostics market.

Applied BioCode’s solution has shown international traction. With premarket clearance FDA 510k and TFDA registrations for Gastrointestinal Pathogen Panel and Respiratory Pathogen Panel in hand, Applied BioCode rapidly increases install bases of its automated molecular system BioCode MDx3000 in North America recently. Based on this very system, Applied BioCode continues to develop Cov-Flu-Plus, Multiplex Fungal Panel, and STI panel plus resistance markers. Applied BioCode aims to boost presence and utility among the top 600 largest reference labs and medical centers in the US, becoming high throughput multiplex diagnostics leader, and collaborates with Taiwan’s high quality healthcare systems.

The diagnostics of infectious disease emphasize on shortening turn around time, which is tall task given the seemingly same syndrome may be caused by entirely different pathogens. To rapidly and simultaneously identify these pathogens, labs often rely on multiple brands of instruments and reagents to get the job done, not to mention the high operational cost.

Applied BioCode’s infectious disease testing panels can provide several tens of pathogen targets results from one single test. The masking feature can also report only specific results according to physician’s requirement, which has helped the labs to collect reimbursement timely. Applied BioCode is excited to introduce these comprehensive and flexible testing solutions to Taiwan’s healthcare systems with affordability.

Applied BioCode’s panels and automated systems were enabled through its proprietary technology, Barcoded Magnetic Beads (BMB). The technology was inspired from traditional black and white barcode, realized through Taiwanese semiconductor processing to achieve miniaturization and massive scale. It can attain as many as 4096 biomarkers identifications from 1 sample, filling the needs of rapid, precise, and high volume in-vitro diagnostics. Applied BioCode retains the infectious disease diagnostics field to itself, while co-develop products with various global diagnostics corps in different fields including pet diagnostics, autoimmune disease, allergy, HLA typing, blood transfusion, microbiota health, and food safety, with an aggregate greater than 50BUSD market size.

Taiwan Healthcare Plus expo will kick off on Dec. 5th in Nangang Exhibition Center I, and Applied BioCode has booth on 4th floor M403.